There are different recognised populations considered at-risk of RA, notably as most recently redefined by a EULAR taskforce.42 These include seropositive arthralgia, clinically suspected arthralgia (CSA), first degree relatives of RA patients and ACPA+individuals with non-specific MSK symptoms. This evidence concerns the gene PRTN3 and rheumatoid arthritis.